Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The importance of angiogenesis for the progressive growth and viability of solid tumors is well established. In contrast, only few data are available for hematologic neoplasms. To investigate the role of angiogenesis in acute myeloid leukemia (AML), bone marrow biopsies from 62 adults with newly diagnosed, untreated AML (day 0) were evaluated. Further studies were done after the completion of remission induction chemotherapy (day 16 of induction chemotherapy, n = 21; complete remission, n = 20). Microvessels were scored in at least 3 areas (×500 field, 0.126 mm2) of the highest microvessel density in representative sections of each bone marrow specimen using immunohistochemistry for von Willebrand factor and thrombomodulin. Microvessel counts were significantly higher in patients with AML (n = 62) compared with control patients (n = 22): median (interquartile range) 24.0 (21.0-27.8)/×500 field vs 11.2 (10.0-12.0)/×500 field, respectively (P < .001). On day 16 of induction chemotherapy, microvessel density was reduced by 60% (44-66) (P < .001) in hypoplastic marrows without residual blasts, in contrast to only 17% (0-37) reduction in hypoplastic marrows with ≥ 5% residual blasts (P < .001 for the difference between both groups). Bone marrow biopsies taken at the time of complete remission displayed a microvessel density in the same range as the controls. In conclusion, there is evidence of increased microvessel density in the bone marrow of patients with AML, which supports the hypothesis of an important role of angiogenesis in AML. Furthermore, these findings suggest that antiangiogenic therapy might constitute a novel strategy for the treatment of AML.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
BENNETT, J. M., CATOVSKY, D., DANIEL, M. T., FLANDRIN, G., GALTON, D. A. G., GRALNICK, H. R., & SULTAN, C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-620 · Cited by 2,926
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Induction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner, N., Carroll, P. R., Flax, J. D., Blumenfeld, W., & Folkman, J. (1993) · PubMed Central · Cited by 1,620
TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION
Gimbrone, M. A., Leapman, S. B., Cotran, R. S., & Folkman, J. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.2.261 · Cited by 903
Pui, C.-H., & Evans, W. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390907 · Cited by 832
Cheson, B. D., Cassileth, P. A., Head, D. R., Schiffer, C. A., Bennett, J. M., Bloomfield, C. D., Brunning, R., Gale, R. P., Grever, M. R., & Keating, M. J. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.5.813 · Cited by 770
Vermeulen, P. B., Gasparini, G., Fox, S. B., Toi, M., Martin, L., Mcculloch, P., Pezzella, F., Viale, G., Weidner, N., Harris, A. L., et al. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00379-6 · Cited by 729
The microtubule-affecting drug paclitaxel has antiangiogenic activity.
Belotti, D., Vergani, V., Drudis, T., Borsotti, P., Pitelli, M. R., Viale, G., Giavazzi, R., & Taraboletti, G. (1996) · PubMed · Cited by 706
Bone marrow angiogenesis and progression in multiple myeloma
Vacca, A., Ribatti, D., Roncali, L., Ranieri, G., Serio, G., Silvestris, F., & Dammacco, F. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb08304.x · Cited by 630
Vacca, A., Ribatti, D., Presta, M., Minischetti, M., Iurlaro, M., Ria, R., Albini, A., Bussolino, F., & Dammacco, F. (1999) · Blood · doi:10.1182/blood.v93.9.3064 · Cited by 599
Endothelial proliferation in tumours and normal tissues: Continuous labelling studies
Hobson, B., & Denekamp, J. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.66 · Cited by 565
Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.
Pérez‐Atayde, A. R., Sallan, S. E., Tedrow, U. B., Connors, S. L., Allred, E. N., & Folkman, J. (1997) · Europe PMC (PubMed Central) · Cited by 553
Miettinen, M., Ae, L., & Chaubal, A. (1994) · PubMed · Cited by 476
Fiedler, W., Graeven, U., Ergün, S., Verago, S., Kilic, N., Stockschläder, M., & Hossfeld, D. K. (1997) · Blood · doi:10.1182/blood.v89.6.1870 · Cited by 437
Halting angiogenesis suppresses carcinoma cell invasion
Skobe, M., Rockwell, P., Goldstein, N., Vosseler, S., & Fusenig, N. E. (1997) · Nature Medicine · doi:10.1038/nm1197-1222 · Cited by 420
Maruyama, I., Bell, C. E., & Majerus, P. W. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.2.363 · Cited by 409
Mukai, K., Rosai, J., & Burgdorf, W. H. C. (1980) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198006000-00008 · Cited by 374
Büchner, T., Hiddemann, W., Wormann, B. J., Löffler, H., Gassmann, W., Haferlach, T., Fonatsch, C., Haase, D. T., Schoch, C., Hossfeld, D. K., et al. (1999) · PubMed · doi:10.1182/blood.v93.12.4116 · Cited by 318
Gasparini, G., Weidner, N., Maluta, S., Pozza, F., Boracchi, P., Mezzetti, M., Testolin, A., & Bevilacqua, P. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550507 · Cited by 305
Fontanini, G., Vignati, S., Basolo, F., Bevilacqua, G., Lucchi, M., Mussi, A., Angeletti, C. A., Ciardiello, F., De Laurentiis, M., & De Placido, S. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.12.881 · Cited by 300
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00027-6 · Cited by 271
Tumor angiogenesis as a predictor of recurrence in gastric carcinoma.
Maeda, K., Chung, Y. S., Takatsuka, S., Ogawa, Y., Sawada, T., Yamashita, Y., Onoda, N., Kato, Y., Nitta, A., & Arimoto, Y. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.2.477 · Cited by 246
Angiogenesis and breast cancer metastasis
Ellis, L., & Fidler, I. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92774-3 · Cited by 232
Rak, J., Filmus, J., & Kerbel, R. S. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00396-6 · Cited by 202
Delivery of Molecular and Cellular Medicine to Solid Tumors
Jain, R. K. (1997) · Microcirculation · doi:10.3109/10739689709148314 · Cited by 198
Fernig, D. G., & Gallagher, J. T. (1994) · Progress in Growth Factor Research · doi:10.1016/0955-2235(94)00007-8 · Cited by 196
Griffin, J., Rambaldi, A., Vellenga, E., Young, D., Ostapovicz, D., & Cannistra, S. (1987) · Blood · doi:10.1182/blood.v70.4.1218.1218 · Cited by 196
Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis
Claffey, K. P., & Robinson, G. S. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437469 · Cited by 194
Senger, D. R. (1996) · Europe PMC (PubMed Central) · Cited by 174
Ribatti, D., Vacca, A., Nico, B., Fanelli, M., Roncali, L., & Dammacco, F. (1996) · European Journal of Haematology · doi:10.1111/j.1600-0609.1996.tb00293.x · Cited by 172
Vinca alkaloids: Anti-vascular effects in a murine tumour
Hill, S. A., Lonergan, S. J., Denekamp, J., & Chaplin, D. J. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90082-q · Cited by 168
Tumor Angiogenesis as a Prognostic Factor in Cervical Carcinoma
Wiggins, D. L., Granai, C. O., Steinhoff, M. M., & Calabresi, P. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1062 · Cited by 150
High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis.
Harrison, J. H., & Lazo, J. S. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39287-6 · Cited by 148
Rajkumar, S. V., Fonseca, R., Witzig, T. E., Gertz, M. A., & Greipp, P. (1999) · Leukemia · doi:10.1038/sj.leu.2401336 · Cited by 147
García‐Monzón, C., Sánchez‐Madrid, F., Garcı́a-Buey, L., Arroyo, A. G., García-Sánchez, A., & Moreno-Otero, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90029-2 · Cited by 127
Hansen, S., Grabau, D., Rose, C., Bak, M., & Sørensen, F. B. (1998) · PubMed · Cited by 124
Hamada, J., Cavanaugh, P., Lotan, O., & Nicolson, G. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.269 · Cited by 107
Schirner, M., Hoffmann, J., Menrad, A., & Schneider, M. R. (1998) · PubMed · Cited by 105
The role of capillarization in hepatic failure: Studies in carbon tetrachloride-induced cirrhosis
Martinez-Hernandez, A., & Martinez, J. (1991) · Hepatology · doi:10.1002/hep.1840140519 · Cited by 105
Bhunchet, E., & Fujieda, K. (1993) · Hepatology · doi:10.1002/hep.1840180626 · Cited by 95
Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study
Vermeulen, P., Verhoeven, D., Fierens, H., Hubens, G., Goovaerts, G., Marck, E. V., de Bruijn, E. A., van Oosterom, A., & Dirix, L. Y. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.68 · Cited by 86
Studies on Capillarization of the Hepatic Sinusoids in Alcoholic Liver Disease
Urashima, S., Tsutsumi, M., Nakase, K., et al. (1993) · Alcohol and Alcoholism · doi:10.1093/alcalc/28.supplement_1b.77 · Cited by 72
Interactions between newly formed endothelial channels and carcinoma cells in plasma clot culture
Nicosia, R. F., Tchao, R., & Leighton, J. (1986) · Clinical & Experimental Metastasis · doi:10.1007/bf00119076 · Cited by 68
Davis, T., Dh, R., Lee, K. P., & Kessler, S. (1995) · Blood · doi:10.1182/blood.v85.7.1751.bloodjournal8571751 · Cited by 67
Vermeulen, P., Libura, M., Libura, J., O‘Neill, P. J., van Dam, P. A., Marck, E. V., van Oosterom, A. T., & Dirix, L. Y. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005737524541 · Cited by 57
Inhibition of Angiogenesis by Anthracyclines and Titanocene Dichloridea
Maragoudakis, M. E., Peristeris, P., Missirlis, E., Aletras, A. J., Andriopoulou, P., & Haralabopoulos, G. C. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb24743.x · Cited by 46
Vascular enumeration as a significant prognosticator for invasive breast carcinoma.
Fernández‐Aceñero, M. J., González, J., Gallego, M., & Ballesteros, P. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1684 · Cited by 39
Dubuisson, L., Boussarie, L., Bedin, C., Balabaud, C. P., & Bioulac‐Sage, P. (1995) · Hepatology · doi:10.1002/hep.1840210330 · Cited by 33
Plasminogen activator in acute myeloid leukaemic marrows: u‐PA in contrast to t‐PA in normal marrow
McWilliam, N. A., ROBBIE, L. A., Booth, N. A., & Bennett, B. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00762.x · Cited by 12
Cited by
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
Presta, M., Dell’Era, P., Mitola, S., Moroni, E., Ronca, R., & Rusnati, M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.004 · Cited by 1,261
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
O'Farrell, A.-M., Abrams, T. J., Yuen, H. A., Ngai, T. J., Louie, S. G., Yee, K. W. H., Wong, L. M., Hong, W., Lee, L. B., Town, A., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2307 · Cited by 864
Clinical Implications of Circulating Angiogenic Factors in Cancer Patients
Poon, R. T.-P., Fan, S.-T., & Wong, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1207 · Cited by 587
Majka, M., Janowska-Wieczorek, A., Ratajczak, J., Ehrenman, K., Pietrzkowski, Z., Kowalska, M. A., Gewirtz, A. M., Emerson, S. G., & Ratajczak, M. Z. (2001) · Blood · doi:10.1182/blood.v97.10.3075 · Cited by 508
Metadata
- Authors
- Padró, T., Ruiz, S., Bieker, R., Bürger, H., Steins, M., Kienast, J., Büchner, T., Berdel, W. E., & Mesters, R. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2000-04-15
- Volume
- 95
- Issue
- 8
- Pages
- 2637-2644
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1567732942
- Cited by
- 476
- References
- 53
- FWCI
- 20.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.